Agile 3+ and Agile 4, noninvasive tests for liver fibrosis, are excellent formulae to predict liver‐related events in nonalcoholic fatty liver disease

K Miura, H Hayashi, Y Kamada, H Fujii… - Hepatology …, 2023 - Wiley Online Library
Abstract Aim The noninvasive tests (NITs) Agile 3+ and Agile 4 effectively identify patients
with nonalcoholic fatty liver disease (NAFLD) complicated with advanced fibrosis (F3–4) and …
被引用次数：7 相关文章

Agile 3+ and Agile 4, non-invasive tests for liver fibrosis, are excellent formulae to predict liver-related events in nonalcoholic fatty liver disease.

K Miura, H Hayashi, Y Kamada, H Fujii… - … Research: the Official …, 2023 - europepmc.org
Aim The non-invasive tests, Agile 3+ and Agile 4, effectively identify patients with
nonalcoholic fatty liver disease (NAFLD) complicated with advanced fibrosis (F3-4) and …

Agile 3+ and Agile 4, noninvasive tests for liver fibrosis, are excellent formulae to predict liver-related events in nonalcoholic fatty liver disease

K Miura, H Hayashi, Y Kamada… - … : the official journal …, 2023 - pubmed.ncbi.nlm.nih.gov
Aim The noninvasive tests (NITs) Agile 3+ and Agile 4 effectively identify patients with
nonalcoholic fatty liver disease (NAFLD) complicated with advanced fibrosis (F3-4) and …

Agile 3+ and Agile 4, noninvasive tests for liver fibrosis, are excellent formulae to predict liver-related events in nonalcoholic fatty liver disease

K Miura, H Hayashi, Y Kamada, H Fujii… - Hepatology …, 2023 - kyushu-u.elsevierpure.com
Aim: The noninvasive tests (NITs) Agile 3+ and Agile 4 effectively identify patients with
nonalcoholic fatty liver disease (NAFLD) complicated with advanced fibrosis (F3–4) and …